Edap Tms S.A. (NASDAQ:EDAP - Get Free Report) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totaling 24,700 shares, adeclineof40.8% from the July 15th total of 41,700 shares. Based on an average daily volume of 51,300 shares, the days-to-cover ratio is currently 0.5 days. Currently,0.1% of the shares of the stock are sold short. Currently,0.1% of the shares of the stock are sold short. Based on an average daily volume of 51,300 shares, the days-to-cover ratio is currently 0.5 days.
Wall Street Analysts Forecast Growth
Several brokerages recently commented on EDAP. Wall Street Zen began coverage on Edap Tms in a research report on Thursday, May 15th. They set a "hold" rating for the company. Piper Sandler cut Edap Tms from an "overweight" rating to a "neutral" rating in a report on Thursday, May 15th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Edap Tms currently has an average rating of "Hold" and an average price target of $8.50.
Check Out Our Latest Stock Analysis on EDAP
Hedge Funds Weigh In On Edap Tms
A number of hedge funds have recently modified their holdings of EDAP. Rock Springs Capital Management LP lifted its stake in Edap Tms by 1.5% during the 4th quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider's stock worth $3,518,000 after acquiring an additional 23,800 shares in the last quarter. Banque Transatlantique SA raised its position in Edap Tms by 7,063.7% in the 1st quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider's stock valued at $1,324,000 after purchasing an additional 720,499 shares in the last quarter. Scoggin Management LP purchased a new position in shares of Edap Tms in the 1st quarter valued at about $686,000. Schonfeld Strategic Advisors LLC increased its holdings in shares of Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider's stock valued at $355,000 after acquiring an additional 52,500 shares during the last quarter. Finally, Sage Mountain Advisors LLC purchased a new position in shares of Edap Tms in the 2nd quarter valued at about $165,000. 62.74% of the stock is currently owned by hedge funds and other institutional investors.
Edap Tms Trading Up 2.2%
Shares of NASDAQ EDAP traded up $0.03 during mid-day trading on Friday, reaching $1.38. 46,293 shares of the company's stock were exchanged, compared to its average volume of 68,332. The firm has a market capitalization of $51.60 million, a price-to-earnings ratio of -2.23 and a beta of -0.09. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.21 and a current ratio of 1.74. Edap Tms has a 52-week low of $1.21 and a 52-week high of $4.22. The company's 50-day moving average is $1.50 and its 200-day moving average is $1.87.
Edap Tms Company Profile
(
Get Free Report)
EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.
Further Reading
Before you consider Edap Tms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edap Tms wasn't on the list.
While Edap Tms currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.